Publications

The Impact of FDA Regulatory Activities on Incident Dispensing of LABA-Containing Medication: 2005-2011.

J Asthma
Baker MA, Butler MG, Seymour S, Zhang F, Wu Y, Wu AC, Levenson MS, Wu P, Iyer A, Toh S, Iyasu S, Zhou EH

A proposed approach to accelerate evidence generation for genomic-based technologies in the context of a learning health system.

Genet. Med.
Lu CY, Williams MS, Ginsburg GS, Toh S, Brown JS, Khoury MJ

Sentinel Modular Program for Propensity-Score Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia.

Epidemiology
Zhou M, Wang SV, Leonard CE, Gagne JJ, Fuller C, Hampp C, Archdeacon P, Toh S, Iyer A, Woodworth TS, Cavagnaro E, Panozzo CA, Axtman S, Carnahan RM, Chrischilles EA, Hennessy S

Administrative Claims Data Versus Augmented Pregnancy Data for the Study of Pharmaceutical Treatments in Pregnancy.

Curr Epidemiol Rep
Andrade SE, Bérard A, Nordeng HME, Wood ME, van Gelder MMHJ, Toh S

Antiemetic use among pregnant women in the United States: the escalating use of ondansetron.

Pharmacoepidemiol Drug Saf
Taylor LG, Bird ST, Sahin L, Tassinari MS, Greene P, Reichman ME, Andrade SE, Haffenreffer K, Toh S

Enrollment and Retention in 34 United States Pregnancy Registries Contrasted with the Manufacturer's Capture of Spontaneous Reports for Exposed Pregnancies.

Drug Saf
Bird ST, Gelperin K, Taylor L, Sahin L, Hammad H, Andrade SE, Mohamoud MA, Toh S, Hampp C

National Trends in Outpatient Antihypertensive Prescribing in People with Dementia in the United States.

J. Alzheimers Dis.
Tan EC, Bell JS, Lu CY, Toh S

Design and analysis choices for safety surveillance evaluations need to be tuned to the specifics of the hypothesized drug-outcome association.

Pharmacoepidemiol Drug Saf
Gruber S, Chakravarty A, Heckbert SR, Levenson M, Martin D, Nelson JC, Psaty BM, Pinheiro S, Reich CG, Toh S, Walker AM

Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association.

Clin. Pharmacol. Ther.
Gagne JJ, Han X, Hennessy S, Leonard CE, Chrischilles EA, Carnahan RM, Wang SV, Fuller C, Iyer A, Katcoff H, Woodworth TS, Archdeacon P, Meyer TE, Schneeweiss S, Toh S

Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration's Mini-Sentinel program.

Arch Womens Ment Health
Andrade SE, Reichman ME, Mott K, Pitts M, Kieswetter C, Dinatale M, Stone MB, Popovic J, Haffenreffer K, Toh S

Uptake of new drugs in the early post-approval period in the Mini-Sentinel distributed database.

Pharmacoepidemiol Drug Saf
Mott K, Graham DJ, Toh S, Gagne JJ, Levenson M, Ma Y, Reichman ME

Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study.

Ann. Intern. Med.
Toh S, Hampp C, Reichman ME, Graham DJ, Balakrishnan S, Pucino F, Hamilton J, Lendle S, Iyer A, Rucker M, Pimentel M, Nathwani N, Griffin MR, Brown NJ, Fireman BH

Surveillance of Medication Use During Pregnancy in the Mini-Sentinel Program.

Matern Child Health J
Andrade SE, Toh S, Houstoun M, Mott K, Pitts M, Kieswetter C, Ceresa C, Haffenreffer K, Reichman ME

Changing patterns of asthma medication use related to US Food and Drug Administration long-acting β2-agonist regulation from 2005-2011.

J. Allergy Clin. Immunol.
Butler MG, Zhou EH, Zhang F, Wu YT, Wu AC, Levenson MS, Wu P, Seymour S, Toh S, Iyer A, Iyasu S, Baker MA

Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies.

Pharmacoepidemiol Drug Saf
Hansen C, Andrade SE, Freiman H, Dublin S, Haffenreffer K, Cooper WO, Cheetham TC, Toh S, Li DK, Raebel MA, Kuntz JL, Perrin N, Rosales AG, Carter S, Pawloski PA, Maloney EM, Graham DJ, Sahin L, Scott PE, Yap J, Davis R

Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities.

Syst Rev
Cameron C, Fireman B, Hutton B, Clifford T, Coyle D, Wells G, Dormuth CR, Platt R, Toh S

Trends in elective labor induction for six United States health plans, 2001-2007.

J Womens Health (Larchmt)
Dublin S, Johnson KE, Walker RL, Avalos LA, Andrade SE, Beaton SJ, Davis RL, Herrinton LJ, Pawloski PA, Raebel MA, Smith DH, Toh S, Caughey AB

Characteristics of study design and elements that may contribute to the success of electronic safety monitoring systems.

Pharmacoepidemiol Drug Saf
Bell C, Chakravarty A, Gruber S, Heckbert SR, Levenson M, Martin D, Nelson JC, Pinheiro S, Psaty BM, Reich CG, Schneeweiss S, Shoaibi A, Toh S, Walker AM

Potential bias of instrumental variable analyses for observational comparative effectiveness research.

Ann. Intern. Med.
Garabedian LF, Chu P, Toh S, Zaslavsky AM, Soumerai SB

Privacy-preserving analytic methods for multisite comparative effectiveness and patient-centered outcomes research.

Med Care
Toh S, Shetterly S, Powers JD, Arterburn D